Home
Flashcards
Preview
Pharmacology Final
Home
Get App
Take Quiz
Create
ADEs with sulfonylureas
less in 2nd generation than first, but still few
Most common ADE with sulfonylureas
hypoglycemia
Sulfonylurea drugs
chlorpropamide
tolazamide
Chlorpropamide & Tolazamide ADEs
hypoglycemia
jaundice
N/V
Anorexia
Pruitis
Disulfiram Like reactions
Meglitinides
only effective in pt w functioning beta cells
may be used in pt with sulfa allergy
Meglitinide MoA
stimulate release of insulin from beta cells by blocking atp dependant K+ channels
Meglitinide metabolism
rapid absorption
recommended pre-prandial administration
hepatic metabolism
major adverse effect of meglitinides
hypoglycemia
Caution with meglitinides
renal or hepatic insuficiency
Drug interactions with meglitinides
ketoconazole
miconazole
erythromycin
decrease biotransformation => hypoglycemia
ex. drug of meglitinide
repaglinide
Repaglinide can be used with
sulfonylureas
metformin
thiazolidinediones
Biguanide
Metformin
Only biguanide in the US
Metformin perks
does not cause hypoglycemia
pt do not gain weight
action does not depend on functioning beta cells
Metformin and food
Food decreases absorption
ADEs with metformin
NVD
anorexia
flatulence
lactic acidosis
Contraindications with metformin
renal or hepatic impairment
Metformin mechanism of action
Increases glucose uptake in the muscles
Decreases gluconeogenesis in the liver
Repaglinide and Metformin combo MoA
Repaglinide lowers BG by stimulating insulin release
Metformin improves glucose tolerance by lowing basal and postprandial BG
Additional contraindications for repaglinide/metformin
pt. receiving gemfibrozil and itraconazole
pt receiving contrast dye
Caution with metformin/repaglinide
alcohol potentiates effect of metformin
should not be used with NPH insulin
may cause B12 deficiency
Hepatic impairment
Drugs that compete with metformin for excretion in the kidney
cationic drugs
amiloride
digoxin
procainamide
Repaglinide metabolized by
CYP2C8 and 3A4
Prandimet (repaglinide/metformin) should be taken ____ meals
with
Thiazolidinediones
pioglitazone
rosiglitazone
TZD MoA
increase insulin sensitivity in tissues
decrease hepatic gluconeogenesis
TZD metabolism
take with or without food
metabolized by CYP450
Drug interactions with TZDs
decreases plasma concentrations of oral contraceptives => pregnancy
not recommended with insulin
not recommended with nitrates
Author
Rx2013
ID
82327
Card Set
Pharmacology Final
Description
Oral Hypoglycemics
Updated
2011-04-27T23:45:33Z
Home
Flashcards
Preview